Publicacións (35) Publicacións nas que participase algún/ha investigador/a

2007

  1. Adenocarcinoma prostático y mieloma múltiple sincrónicos: A prospósito de un caso

    Actas Urologicas Espanolas, Vol. 31, Núm. 2, pp. 157-159

  2. Advanced breast cancer: Chemotherapy phase III trials that change a standard

    Anti-Cancer Drugs

  3. Alpha(1,6)fucosyltransferase lmmunohistochemical expression and the survival of patients with colorectal cancer

    EJC SUPPLEMENTS

  4. Bias in association studies of systemic lupus erythematosus susceptibility due to geographical variation in the frequency of a programmed cell death 1 polymorphism across Europe

    Genes and Immunity, Vol. 8, Núm. 2, pp. 138-146

  5. Biweekly administration of docetaxel and vinorelbine as second-line chemotherapy for patients with stage IIIB and IV non-small cell lung cancer: A phase II study of the Galician Lung Cancer Group (GGCP 013-02)

    Anti-Cancer Drugs, Vol. 18, Núm. 10, pp. 1201-1206

  6. Bone marrow cells adopt the cardiomyogenic fate in vivo

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 104, Núm. 45, pp. 17783-17788

  7. Choroid plexus carcinoma: A rare condition and its therapeutic management

    Clinical and Translational Oncology, Vol. 9, Núm. 6, pp. 401-403

  8. Current controversies in the management of early breast cancer

    Clinical and Translational Oncology, Vol. 9, Núm. 6, pp. 375-384

  9. Customizing cisplatin based on quantitative excision repair cross-complementing 1 mRNA expression: A phase III trial in non-small-cell lung cancer

    Journal of Clinical Oncology, Vol. 25, Núm. 19, pp. 2747-2754

  10. Cyclooxygenase-2 (COX-2): A molecular target in prostate cancer

    Clinical and Translational Oncology, Vol. 9, Núm. 11, pp. 694-702

  11. Derrame pleural tipo trasudado como expresión de afectación pleural por amiloidosis

    Revista Clinica Espanola

  12. Disseminated classic Kaposi's sarcoma

    Clinical and Translational Oncology, Vol. 9, Núm. 4, pp. 255-257

  13. Docetaxel-induced interstitial pneumonitis following non-small-cell lung cancer treatment

    Clinical and Translational Oncology, Vol. 9, Núm. 9, pp. 578-581

  14. Evidence-based use of taxanes in the adjuvant setting of breast cancer. A review of randomized phase III trials

    Cancer Treatment Reviews, Vol. 33, Núm. 5, pp. 474-483

  15. Gemcitabine plus docetaxel as first-line chemotherapy in patients with advanced non-small cell lung cancer: A lung cancer Galician group phase II study

    Cancer Chemotherapy and Pharmacology, Vol. 60, Núm. 5, pp. 725-732

  16. Gemcitabine plus vinorelbine versus vinorelbine monotherapy in patients with metastatic breast cancer previously treated with anthracyclines and taxanes: final results of the phase III Spanish Breast Cancer Research Group (GEICAM) trial

    Lancet Oncology, Vol. 8, Núm. 3, pp. 219-225

  17. Gliomatosis Cerebri: diagnóstico y tratamiento con temozolomida, a propósito de un caso

    Oncología, Vol. 30, Núm. 3, pp. 41-45

  18. Gliomatosis cerebri: Diagnóstico y tratamiento con temozolomida, a propósito de un caso

    Oncologia, Vol. 30, Núm. 3, pp. 41-45

  19. Guía de práctica clínica: cancro de pulmón e mesotelioma

    Conselleria de Sanidade

  20. Lack of effect of the ghrelin gene-derived peptide obestatin on cardiomyocyte viability and metabolism

    Journal of Endocrinological Investigation, Vol. 30, Núm. 6, pp. 470-476